You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INCB018424

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)

Approved for marketing
  • Graft-versus-host Disease (GVHD)
  • (no location specified)
Jan 26, 2023

Prurigo Trial (Ruxolitinib Cream, Vehicle Cream)

Not yet recruiting
  • Prurigo
  • Ruxolitinib Cream
  • Vehicle Cream
  • (no location specified)
Feb 23, 2023

Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)

Not yet recruiting
  • Prurigo Nodularis
  • Ruxolitinib Cream
  • Vehicle Cream
  • (no location specified)
Mar 1, 2023

Psoriasis Trial in United States (Ruxolitinib phosphate cream, Dovonex® calcipotriene 0.005%, Diprolene® AF betamethasone

Completed
Has Results
  • Psoriasis
  • Ruxolitinib phosphate cream
  • +3 more
  • Vallejo, California
  • +5 more
Feb 7, 2022

Lichen Planus Trial in Scottsdale (INCB018424)

Completed
Has Results
  • Lichen Planus
  • INCB018424
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 2, 2021

Atopic Dermatitis Trial in East Syracuse, Arlington (ruxolitinib cream)

Recruiting
  • Atopic Dermatitis
  • ruxolitinib cream
  • East Syracuse, New York
  • +1 more
Jan 13, 2023

Atopic Dermatitis Trial in Montreal (ruxolitinib cream)

Recruiting
  • Atopic Dermatitis
  • ruxolitinib cream
  • Montreal, Quebec, Canada
    Innovoderm Research
Jul 12, 2022

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical

Recruiting
  • Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
  • topical ruxolitinib 1.5% cream
  • Topical vehicle/moisturizer cream
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 20, 2022

Lichen Sclerosus Trial in Canada, United States (Ruxolitinib cream, Vehicle cream)

Recruiting
  • Lichen Sclerosus
  • Ruxolitinib cream
  • Vehicle cream
  • Birmingham, Alabama
  • +4 more
Dec 13, 2022

COVID-19 Trial (Ruxolitinib)

No longer available
  • COVID-19
  • (no location specified)
Dec 1, 2021

Psoriasis Trial in United States (Placebo Cream, Ruxolitinib Phosphate)

Completed
Has Results
  • Psoriasis
  • Placebo Cream
  • Ruxolitinib Phosphate
  • Hot Springs, Arkansas
  • +27 more
Jan 12, 2022

Psoriasis Trial in United States (Ruxolitinib)

Completed
Has Results
  • Psoriasis
  • Fridley, Minnesota
  • +3 more
Feb 4, 2022

Cutaneous Lichen Planus Trial in Canada, United States (Ruxolitinib cream, Vehicle cream)

Recruiting
  • Cutaneous Lichen Planus
  • Ruxolitinib cream
  • Vehicle cream
  • Birmingham, Alabama
  • +6 more
Dec 1, 2022

Vitiligo Trial in United States (Ruxolitinib cream, Vehicle cream)

Completed
Has Results
  • Vitiligo
  • Ruxolitinib cream
  • Vehicle cream
  • Birmingham, Alabama
  • +25 more
Dec 8, 2021

Myelomonocytic Leukemia Trial in United States (Ruxolitinib)

Completed
Has Results
  • Myelomonocytic Leukemia
  • Tampa, Florida
  • +5 more
Sep 9, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Atopic Dermatitis, Open Label Trial in United States (Ruxolitinib cream)

Active, not recruiting
  • Atopic Dermatitis
  • Open Label
  • Ruxolitinib cream
  • Gilbert, Arizona
  • +14 more
Jul 29, 2022

Vitiligo Trial in Canada, France, United States (Ruxolitinib cream, Vehicle Cream)

Recruiting
  • Vitiligo
  • Ruxolitinib cream
  • Vehicle Cream
  • Fountain Valley, California
  • +12 more
Mar 24, 2022

Primary Myelofibrosis, Secondary Myelofibrosis, PMF Trial in Germany (INCB018424/CC-4047)

Active, not recruiting
  • Primary Myelofibrosis
  • +5 more
  • Aachen, Germany
  • +16 more
Sep 28, 2021

Chronic Phase Chronic Myeloid Leukemia Trial in Tampa (Nilotinib, Ruxolitinib)

Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 4, 2021

Vitiligo Trial in Boston (Ruxolitinib 1.5% Phosphate Cream)

Completed
Has Results
  • Vitiligo
  • Ruxolitinib 1.5% Phosphate Cream
  • Boston, Massachusetts
    Tufts Medical Center
Aug 21, 2020

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (INCB018424)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +3 more
  • INCB018424
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2020

Hidradenitis Suppurativa Trial in Canada, Poland, United States (Ruxolitinib cream, Vehicle cream)

Recruiting
  • Hidradenitis Suppurativa
  • Ruxolitinib cream
  • Vehicle cream
  • Phoenix, Arizona
  • +26 more
Dec 13, 2022

Atopic Dermatitis Trial in Canada, United States (Ruxolitinib 0.15% Cream QD, Ruxolitinib 0.5% Cream QD, Ruxolitinib 1.5% Cream

Completed
Has Results
  • Atopic Dermatitis
  • Ruxolitinib 0.15% Cream QD
  • +5 more
  • Birmingham, Alabama
  • +51 more
Mar 16, 2021